Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Artios Pharma Ltd
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Frontier Medicines Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Beijing Biotech
National Cancer Institute (NCI)
Jules Bordet Institute
Centre Oscar Lambret
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Mayo Clinic
Mayo Clinic
Tomsk National Research Medical Center of the Russian Academy of Sciences
National Institutes of Health Clinical Center (CC)
Taiho Oncology, Inc.
Kivu Bioscience Inc.
Federation Francophone de Cancerologie Digestive
Alterome Therapeutics, Inc.
Verastem, Inc.
Fudan University
Imugene Limited
Eli Lilly and Company
I-Mab Biopharma US Limited
University of California, Davis
BicycleTx Limited
Huazhong University of Science and Technology
M.D. Anderson Cancer Center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Fudan University
M.D. Anderson Cancer Center
Centre Leon Berard
Coherus Oncology, Inc.
ViroMissile, Inc.
I-Mab Biopharma US Limited
Ohio State University Comprehensive Cancer Center
Pfizer
Astellas Pharma Inc
Cedars-Sinai Medical Center
Boston Scientific Corporation
Pfizer